Mumbai based pharma major, Lupin Ltd. announced that the company and its subsidiaries, Lupin Pharmaceuticals, Inc., and Lupin Atlantis Holding SA have entered into a license agreement with Abbott Laboratories and Laboratoires Fournier SA for various Abbott licensed patents for Antara (Fenofibrate) capsules.

The licensed patents include, collectively, US Patent Nos. 4,895,726; 6,074,670; 6,277,405; 6,589,552; 7,037,529; 7,041,319; 6,596,317 and 6,652,881, and any divisionals, continuations, continuations in part, reissues, re-examinations, and extensions thereof.

The company has not disclosed the terms of the patent license agreement.